For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech giants, as well as popular consumer-facing stocks. What if you'd invested in HCA Healthcare (HCA) ten years ago? It may not have been easy to hold on to HCA for all that time, but if you did, how much would your investment be worth today? HCA Healthcare's Business In-Depth With that in mind, let's take a look at HCA Healthcare's main business drivers. HCA Healthcare is the largest non-governmental operator of acute care hospitals in the United States. Headquartered in Nashville, TN, it operates hospitals and related health care entities. At the end of 2024, the company operated 190 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom. It also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (“ASCs”), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices and various other facilities. The company operates in two geographically organized groups, the National and American Groups. HCA generated revenues of $70.6 billion in 2024. The National Group (accounted for 27.8% of the overall 2024 revenues) had 55 hospitals located in states like Alaska, California, Idaho, Indiana, Kentucky, Nevada, New Hampshire, North Carolina, Tennessee, Utah and Virginia. The American Group (34.8%) has 65 hospitals in states like Colorado, Central Kansas, Louisiana and Texas. Its Atlantic Group (32.8%) included 62 hospitals located in Florida, Georgia, Northern Kansas, Missouri and South Carolina. The company also operates seven hospitals in England that are included in the Corporate and Other group (4.6%). The company's 180 general, acute care hospitals with 49,114 licensed beds provide a wide range of services to cater to different medical specialties, such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics as well as diagnostic and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. Its six behavioral hospitals with 602 licensed beds offer child, adolescent and adult psychiatric care. It also provides adolescent and adult alcohol and drug abuse treatment and counseling. Story Continues Bottom Line Putting together a successful investment portfolio takes a combination of research, patience, and a little bit of risk. For HCA Healthcare, if you bought shares a decade ago, you're likely feeling really good about your investment today. According to our calculations, a $1000 investment made in May 2015 would be worth $4,746.37, or a 374.64% gain, as of May 6, 2025. Investors should keep in mind that this return excludes dividends but includes price appreciation. In comparison, the S&P 500 gained 170.42% and the price of gold went up 168.35% over the same time frame. Going forward, analysts are expecting more upside for HCA. HCA Healthcare beat 1Q25 earnings estimates on strong patient volumes. Its revenues remain on an uptick on the back of growth in admissions and inpatient surgeries. The resumption of deferred elective procedures is likely to sustain the trend. Revenues are anticipated to be between $72.8 billion and $75.8 billion in 2025, the midpoint of which indicates a 5.2% rise from the 2024 figure. Multiple buyouts aided in increasing patient volumes and added hospitals to the portfolio. HCA Healthcare resorts to prudent capital deployment via share buybacks and dividend payments. Its shares have outperformed the industry in the past year. However, a debt-heavy balance sheet induces a rise in interest expenses. The company had a long-term debt of $44.58 billion. Also, escalating expenses may strain margins. As such, the stock warrants a cautious stance. Over the past four weeks, shares have rallied 5.99%, and there have been 7 higher earnings estimate revisions in the past two months for fiscal 2025 compared to none lower. The consensus estimate has moved up as well. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HCA Healthcare, Inc. (HCA):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...